Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C2CH
|
|||
Former ID |
DIB000521
|
|||
Drug Name |
OGT-719
|
|||
Synonyms |
OGS-719
Click to Show/Hide
|
|||
Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Discontinued in Phase 2 | [1] | |
Company |
Oxford GlycoSciences plc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C10H13FN2O7
|
|||
Canonical SMILES |
C1=C(C(=O)NC(=O)N1C2C(C(C(C(O2)CO)O)O)O)F
|
|||
InChI |
1S/C10H13FN2O7/c11-3-1-13(10(19)12-8(3)18)9-7(17)6(16)5(15)4(2-14)20-9/h1,4-7,9,14-17H,2H2,(H,12,18,19)/t4-,5+,6+,7-,9-/m1/s1
|
|||
InChIKey |
YHWGRVDTEORPPJ-WENHOLORSA-N
|
|||
CAS Number |
CAS 185843-61-2
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009854) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.